Login

Financial Snapshot

Revenue
TTM
$296.1M
Gross Margin
TTM
67.25%
Net Income
TTM
-$6.053M
Current Assets
2026 Q1
Current Liabilities
2026 Q1
Current Ratio
2026 Q1
178.92%
Total Assets
2026 Q1
Total Liabilities
2026 Q1
Book Value
2026 Q1
$55.24M
Cash
2026 Q1
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
$24.69M

Stock Price

Loading...
Market Cap: $86.249 Million

About Skinhealth Systems Inc

Skinhealth Systems Inc (SKIN) is a medical aesthetics company that develops and sells the Hydrafacial platform, a non-invasive skin treatment system sold to professional providers. The company operates on a razor/razor blade model: Delivery Systems (the device hardware) are sold to providers as capital equipment, while single-use Consumables including tips, solutions, serums, and Boosters generate recurring revenue each time a treatment is performed. Hydrafacial went public in May 2021 through a business combination with Vesper Healthcare Acquisition Corp, a Delaware-incorporated SPAC. The company manufactures its Delivery Systems at a facility in Long Beach, California, and outsources manufacturing of other products to contract manufacturers in North America, Europe, and Asia. The product line also includes the SkinStylus SteriLock Microsystem, an FDA-cleared Class II medical device used for microneedling and nano-channeling treatments. The platform targets providers across medical spas, dermatology practices, and aesthetic clinics, with treatments positioned as repeatable and compatible with combination therapy protocols.

Revenue model
Razor/razor blade model. Delivery Systems are sold as capital equipment on a transactional basis. Consumables, including single-use tips, solutions, serums, and Boosters, are purchased periodically by providers and generate recurring revenue. Both Delivery Systems and Consumables can be sold together or separately.
Products and services
Hydrafacial Delivery Systems (device hardware for provider use); Consumables including single-use tips, solutions, serums, and Boosters; SkinStylus SteriLock Microsystem (FDA-cleared Class II medical device for microneedling using 12-pin, 36-pin, and 36-pin HiLo cartridges, and nano-channeling applications).
Customers and end markets
Professional aesthetics providers including medical spas, dermatology practices, and aesthetic clinics. End consumers are patients and clients seeking non-invasive skin treatments. Treatments are described as suitable across genders, age groups, skin tones, and skin types.
Value-chain role
Manufacturer and distributor of aesthetic device hardware and single-use consumable products sold directly to professional providers. Delivery System manufacturing and assembly is performed in-house in Long Beach, California; other products are manufactured by third-party contract manufacturers primarily in North America, Europe, and Asia.
Geographic exposure
Manufacturing based in Long Beach, California. Contract manufacturers located in North America, Europe, and Asia. No specific revenue geographic breakdown is supported by the filing excerpts provided.

Source: SEC 10-K, filed 2026-03-12

Industry: Surgical & Medical Instruments & Apparatus Peers: Bellring Brands Inc elf Beauty Inc Edgewell Personal Care Co Estee Lauder Companies Inc Veru Inc Medifast Inc Interparfums Inc NU Skin Enterprises Inc USANA Health Sciences Inc Waldencast PLC

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support